Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Tapan M. Kadia"'
Autor:
Farhad Ravandi, Nitin Jain, Naval Daver, Courtney D. DiNardo, Guillermo Garcia-Manero, Kebede H. Begna, Hagop M. Kantarjian, Guillermo Montalban Bravo, Nicholas J. Short, Ayalew Tefferi, Tapan M. Kadia, Lucia Masarova, Sherry Pierce, Gautam Borthakur, Koji Sasaki, Elias Jabbour, Marina Konopleva
Publikováno v:
American Journal of Hematology. 97:68-78
The progress with intensive chemotherapy and supportive care measures has improved survival in patients with newly diagnosed acute myeloid leukemia (AML). Given the recent development of effective low intensity therapies, an optimal decision on the t
Autor:
Patrick K, Reville, Koji, Sasaki, Hagop M, Kantarjian, Naval G, Daver, Musa, Yilmaz, Courtney D, Dinardo, Nicholas J, Short, Gautam, Borthakur, Naveen, Pemmaraju, Rohtesh S, Mehta, Sherry, Pierce, Sergej N, Konoplev, Joseph D, Khoury, Guillermo, Garcia-Manero, Marina Y, Konopleva, Elias, Jabbour, Farhad, Ravandi, Tapan M, Kadia
Publikováno v:
Am J Hematol
Mutations in in fms-like tyrosine kinase 3 (FLT3) gene are common genomic alterations in acute myeloid leukemia (AML). FLT3 internal tandem duplication mutations (FLT3-ITD) have consistently been shown to be adversely prognostic, particularly those w
Autor:
Keyur P. Patel, Michael Andreeff, Zhihong Zeng, Naval Daver, Gautam Borthakur, Hsiang Chun Chen, Ru Yiu Wang, Teresa McQueen, Marina Konopleva, Mary A. Kelly, Hagop M. Kantarjian, Jorge E. Cortes, Tapan M. Kadia, Xuelin Huang, Farhad Ravandi
Publikováno v:
American Journal of Hematology. 95:1296-1303
Stroma-leukemia interactions mediated by CXCR4, CD44, VLA4, and their respective ligands contribute to therapy resistance in FLT3-ITD-mutated acute myelogenous leukemia (AML). We conducted a phase 1 study with the combination of sorafenib (a FLT3-ITD
Autor:
Sherry Pierce, Musa Yilmaz, Yesid Alvarado-Valero, Marina Konopleva, Courtney D. Di Nardo, Sa A. Wang, Jeffrey L. Jorgensen, Koji Sasaki, Rebecca Garris, Farhad Ravandi-Kashani, Jan A. Burger, April Ingram, Zeev Estrov, Hagop M. Kantarjian, Maro Ohanian Do, Jorge E. Cortes, Elias Jabbour, Nicholas J. Short, William G. Wierda, Joseph D. Khoury, Nitin Jain, Naval Daver, Susan OʼBrien, Tapan M. Kadia, Guillermo Garcia-Manero
Publikováno v:
American Journal of Hematology. 95:734-739
Liposomal vincristine is designed to reduce neurotoxicity and increase dose intensity delivery, and has been approved as salvage therapy in relapsed/refractory acute lymphoblastic leukemia (ALL). Our aim was to evaluate the response rate, toxicities,
Autor:
Joseph D. Khoury, Hagop M. Kantarjian, Naval Daver, Rashmi Kanagal-Shamanna, Kiran Naqvi, Mark J. Routbort, Gautam Borthakur, Jorge E. Cortes, Tapan M. Kadia, Nicholas J. Short, Koichi Takahashi, Farhad Ravandi, Keyur P. Patel, Elias Jabbour, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Koji Sasaki, Carlos E. Bueso-Ramos, Marina Konopleva, Ghayas C. Issa, Courtney D. DiNardo, Sherry Pierce, Caleb A. Class, Kim Anh Do
Publikováno v:
American Journal of Hematology. 95:612-622
Acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) is a heterogeneous disorder defined by multilineage dysplasia, myelodysplastic syndrome (MDS)-related karyotype, or history of prior MDS. We evaluated 415 patients with AML-MRC trea
Autor:
Marina Konopleva, Nitin Jain, Iman Abou Dalle, Farhad Ravandi, Partow Kebriaei, Wei Qiao, Elias Jabbour, Guillermo Garcia-Manero, Susan O'Brien, Tapan M. Kadia, Rebecca Garris, Nicholas J. Short, Hagop M. Kantarjian, Jorge E. Cortes
Publikováno v:
American Journal of Hematology. 94:1388-1395
Despite the advances in the management of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) with the introduction of tyrosine kinase inhibitors (TKIs), relapses remain challenging. We reviewed clinical data from adult patients
Autor:
Tapan M. Kadia, Ayalew Tefferi, Horatiu Olteanu, Courtney D. DiNardo, Elias Jabbour, Ginna L. Granroth, Naseema Gangat, Aref Al-Kali, Mrinal M. Patnaik, Marina Konopleva, Naveen Pemmaraju, James M. Foran
Publikováno v:
American journal of hematology. 97(2)
Autor:
Carlos E. Bueso-Ramos, Guillermo Garcia-Manero, Srdan Verstovsek, Guillermo Montalban-Bravo, Keyur P. Patel, Hagop M. Kantarjian, Elias Jabbour, Prithviraj Bose, Naveen Pemmaraju, Tapan M. Kadia, Rashmi Kanagal-Shamanna, Maria Tariq Siddiqui, Koji Sasaki, Farhad Ravandi, Kim Anh Do, Yue Wei, Faezeh Darbaniyan, Courtney D. DiNardo, Kelly S. Chien, Kiran Naqvi, Sherry Pierce, Naval Daver, Hui Yang
Publikováno v:
American Journal of Hematology. 96
Autor:
Courtney D. DiNardo, Naval Daver, Nicholas J. Short, Naveen Pemmaraju, Farhad Ravandi, Prithviraj Bose, Graciela M. Nogueras González, Sanam Loghavi, Sherry Pierce, Kiran Naqvi, Marina Konopleva, Guillermo Garcia-Manero, Iman Abou Dalle, Hagop M. Kantarjian, Gautam Borthakur, Jorge E. Cortes, Koji Sasaki, Michael Andreeff, Fevzi Firat Yalniz, Musa Yilmaz, Tapan M. Kadia, Keyur P. Patel
Publikováno v:
American Journal of Hematology. 94:984-991
Internal tandem duplication (ITD) of the fms-related tyrosine kinase-3 gene (FLT3) confer a poor prognosis in adult AML. Studies have reported that a higher mutant allelic burden is associated with a worse prognosis. Adult patients with FLT3-ITD muta
Autor:
Hagop M. Kantarjian, Sherry Pierce, Yasmin Abaza, Aditya Shetty, Wei Qiao, Naveen Pemmaraju, Jorge E. Cortes, Guillermo Garcia-Manero, Farhad Ravandi, Tapan M. Kadia, Gautam Borthakur
Publikováno v:
American Journal of Hematology. 93:E357-E360